Table 3.

ANCOVA analysis with change in ASM after 6 months of intensive treatment as the dependent variable in type 2 diabetes patients

Fixed factor	n	Estimated change	p value
Sex
Men	51	0.012 ± 0.120	0.809
Women	21	0.065 ± 0.187
Median age (65 years)
Below median	37	0.088 ± 0.141	0.541
Above median	35	−0.037 ± 0.145
Median baseline BMI (27 kg/m2)
Below median	36	−0.212 ± 0.140	0.021
Above median	36	0.266 ± 0.140
Median baseline VFA (110 cm2)
Below median	36	−0.178 ± 0.140	0.045
Above median	36	0.232 ± 0.140
Median baseline HbA1c (9.2%)
Below median	37	−0.015 ± 0.144	0.678
Above median	35	0.072 ± 0.148
Median SMI of men (7.25 kg/m2)
Below median	26	0.212 ± 0.178	0.157
Above median	25	−0.154 ± 0.182
Median SMI of women (6.40 kg/m2)
Below median	10	0.075 ± 0.218	0.702
Above median	11	−0.043 ± 0.208
Utilization of insulin
No	32	−0.119 ± 0.150	0.196
Yes	40	0.144 ± 0.134
Utilization of biguanide
No	33	−0.095 ± 0.148	0.267
Yes	39	0.131 ± 0.136

Covariate was Δbody weight

ASM appendicular skeletal muscle mass, BMI body mass index, VFA visceral fat area, SMI skeletal mass index